MktsMarkets

CalciMedica, Inc.
NASDAQ: CALCKey statistics
CALC News
Stories mentioning CALC from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 3,485 | 3,107 | 3,851 | 4,052 | 4,224 | 3,831 | 3,546 | 4,157 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 5,611 | 4,385 | 5,618 | 6,621 | 6,497 | 6,172 | 5,736 | 6,529 |
| Operating Income (Loss) | (5,611) | (4,385) | (5,618) | (6,621) | (6,497) | (6,172) | (5,736) | (6,529) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 0.00 | 269.00 | (307.00) | 0.00 | 0.00 | |||
| Pretax Income | ||||||||
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income (Loss) | 4,976 | (10,760) | (7,804) | (5,956) | (5,042) | (4,258) | (5,618) | (3,954) |
| Earnings Per Share (Basic) | 0.31 | (0.72) | (0.52) | (0.40) | (0.36) | (0.38) | (0.50) | (0.36) |
| Earnings Per Share (Diluted) | 0.30 | (0.72) | (0.52) | (0.40) | (0.36) | (0.38) | (0.50) | (0.36) |
| Weighted Average Shares Outstanding (Basic) | 15,822 | 15,011 | 15,076 | 14,995 | 14,122 | 11,246 | 11,135 | 11,129 |
| Weighted Average Shares Outstanding (Diluted) | 16,329 | 15,011 | 15,076 | 14,995 | 14,122 | 11,246 | 11,135 | 11,129 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About CALC
CalciMedica, Inc. (NASDAQ: CALC) is a stock listed on the Nasdaq Stock Market under the ticker symbol CALC. It last traded at $1.14 (Nov 19, 2026, 1:33 PM ET), down 2.6% on the day. That gives CalciMedica a market capitalisation of $7.9M.
Over the past 52 weeks CALC has traded between $1.00 and $36.00.
Net income for the quarter ended Mar 31, 2026 was $5.0M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | $5.0M |
| Dec 31, 2025 | — | -$10.8M |
| Sep 30, 2025 | — | -$7.8M |
| Jun 30, 2025 | — | -$6.0M |
From CalciMedica’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…